A tamoxifen study claims that a combination of chemotherapy and the hormone therapy tamoxifen is more effective than tamoxifen alone in preventing breast cancer. In the study, a group of researchers from the U.S. and Canada studied 1477 postmenopausal women with early-stage breast cancer. The women were randomly assigned to one of three study groups. The first group of 361 received tamoxifen alone on a daily basis for five years. The second group of 566 received chemotherapy and tamoxifen for six months, and then completed five years of tamoxifen treatment. And the third group of 550 received chemotherapy alone for six months followed by five years of tamoxifen treatment. All 1477 patients knew which treatment they were receiving. In this study, which is the control group? the third group of 550 that received chemotherapy alone for 6 months and then tamoxifen for 5 years the second group of 566 that received tamoxifen and chemotherapy concurrently for 6 months the first group of 361 that received tamoxifen alone the 1477 postmenopausal women There is no control group. This study is not blind. not an experiment double-blind blind, but not double-blind none of the above
A tamoxifen study claims that a combination of chemotherapy and the hormone therapy tamoxifen is more effective than tamoxifen alone in preventing breast cancer. In the study, a group of researchers from the U.S. and Canada studied 1477 postmenopausal women with early-stage breast cancer. The women were randomly assigned to one of three study groups. The first group of 361 received tamoxifen alone on a daily basis for five years. The second group of 566 received chemotherapy and tamoxifen for six months, and then completed five years of tamoxifen treatment. And the third group of 550 received chemotherapy alone for six months followed by five years of tamoxifen treatment. All 1477 patients knew which treatment they were receiving. In this study, which is the control group? the third group of 550 that received chemotherapy alone for 6 months and then tamoxifen for 5 years the second group of 566 that received tamoxifen and chemotherapy concurrently for 6 months the first group of 361 that received tamoxifen alone the 1477 postmenopausal women There is no control group. This study is not blind. not an experiment double-blind blind, but not double-blind none of the above
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Question
Question #11
A tamoxifen study claims that a combination of chemotherapy and the hormone therapy tamoxifen is more effective than tamoxifen alone in preventing breast cancer. In the study, a group of researchers from the U.S. and Canada studied 1477 postmenopausal women with early-stage breast cancer. The women were randomly assigned to one of three study groups. The first group of 361 received tamoxifen alone on a daily basis for five years. The second group of 566 received chemotherapy and tamoxifen for six months, and then completed five years of tamoxifen treatment. And the third group of 550 received chemotherapy alone for six months followed by five years of tamoxifen treatment. All 1477 patients knew which treatment they were receiving.
In this study, which is the control group?
- the third group of 550 that received chemotherapy alone for 6 months and then tamoxifen for 5 years
- the second group of 566 that received tamoxifen and chemotherapy concurrently for 6 months
- the first group of 361 that received tamoxifen alone
- the 1477 postmenopausal women
- There is no control group.
This study is
- not blind.
- not an experiment
- double-blind
- blind, but not double-blind
- none of the above
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
Similar questions
Recommended textbooks for you
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman